The Food and Drug Administration (FDA) recently heeded the call of Sens. Rob Portman (R-Ohio) and Sherrod Brown (D-Ohio) to expedite its approval of on-site rapid Ebola testing technology.

The Department of Defense uses a rapid diagnostic test in West Africa, but the FDA had not approved the technology for commercial use in the United States. Rapid diagnostic technology saves time because a blood sample can be read more quickly without the use of an outside lab.

Portman and Brown wrote a letter to FDA Commissioner Margaret Hamburg requesting a quick and careful review of the rapid testing technologies.

To read the full article, click the link below.